HIGHLIGHTS
- who: Teruhiko Imamura et al. from the The Second Department of Internal Medicine, University of Toyama, Sugitani, Toyama, Japan have published the research: Prognostic Impact of Polypharmacy following Trans-Catheter Aortic Valve Replacement, in the Journal: (JOURNAL) of 30/03/2023
- what: The authors investigated the prognostic impact of polypharmacy, which was defined as a medication number u226510 at index discharge following TAVR, among an elderly cohort of patients with severe aortic stenosis. The authors focused on the number of medications, and did not determine any specific medication that may have had a negative prognostic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.